Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism.
[en] This study compared the impact on carbohydrate metabolism of two combinedoral contraceptives (COCs). This open-label, single-center trial enrolled participants for a total of 15 cycles. Thirty-six women were randomized to receive either 20 microg ethinyl estradiol (EE) and 75 microg gestodene (GSD) or 20 microg ethinyl estradiol and 150 microg desogestrel (DSG) daily for 21 days out of 28. A glucose tolerance test was performed at baseline and cycles 6 and 13. The area under the curve (AUC) for glucose increased in both study groups. The change was statistically significant (p = 0.036) for the 20 EE/75 GSD group at cycle 6 versus baseline. Fasting blood glucose at cycle 13 was significantly (p < 0.01) higher for both treatment groups compared to baseline. No changes were found for fasting insulin and fasting C-peptide levels or for the AUCs of insulin or C-peptide. Both regimens were well tolerated. Gestodene and desogestrel in combination with 20-microg ethinyl estradiol induce similar changes in carbohydrate metabolism which are smaller than those described earlier for COCs containing higher estrogen doses or more androgenic progestins such as levonorgestrel.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics) Endocrinology, metabolism & nutrition
Author, co-author :
Ludicke, Frank
Gaspard, Ulysse ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique
Demeyer, Fabienne ; Université de Liège - ULiège > Gynécologie-Obstétrique-Sénologie
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Lefebvre, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Language :
English
Title :
Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism.
Godsland, I.F., The influence of female sex steroids on glucose metabolism and insulin action (1996) J Intern Med, 240 (SUPPL. 738), pp. 1-60
Paulus, D., Saint-Remy, A., Jeanjean, M., Oral contraception and cardiovascular risk factors during adolescence (2000) Contraception, 62, pp. 113-116
Kuhl, H., Comparative pharmacology of newer progestogens (1996) Drugs, 51, pp. 188-215
Gaspard, U.J., Wery, O.J., Scheen, A.J., Jaminet, C., Lefebvre, P.J., Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women (1999) Climacteric, 2, pp. 93-100
Rimm, E.B., Manson, J.E., Stampfer, M.J., Oral contraceptive use and the risk of type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women (1992) Diabetologia, 35, pp. 967-972
Oral contraceptives: No apparent association with diabetic complications (1994) Worlds Drug Information, 8, pp. 135-136
Gaspard, U.J., Lefebvre, P.J., Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease (1990) Am J Obstet Gynecol, 163, pp. 334-343
Despres, J.P., Lamarche, B., Mauriege, P., Hyperinsulinemia as an independent risk factor for ischemic heart disease (1996) N Engl J Med, 334, pp. 952-957
Fahmy, K., Abdel-Razik, M., Shaaraway, M., Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile (1991) Contraception, 44, pp. 419-430
Shamma, F.N., Rossi, G., HajHassan, L., The effect of Norplant on glucose metabolism under hyperglycemic hyperinsulinemic conditions (1995) Fertil Steril, 63, pp. 767-772
Spellacy, W.N., Buhi, W.C., Birk, S.A., The effects of norgestrel on carbohydrate and lipid metabolism over one year (1976) Am J Obstet Gynecol, 125, pp. 984-986
Kojima, T., Lindheim, S.R., Duffy, D.M., Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives (1993) Am J Obstet Gynecol, 169, pp. 1540-1544
Godsland, I.F., Walton, C., Felton, C., Insulin resistance, secretion, and metabolism in users of oral contraceptives (1992) J Clin Endocrinol Metab, 74, pp. 64-70
Crook, D., Godsland, I., Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism (1998) Contraception, 57, pp. 189-201
Fioretti, P., Fruzzetti, F., Navalesi, R., Clinical and metabolic effects of a pill containing 30 mcg ethinylestradiol plus 75 mcg gestodene (1989) Contraception, 40, pp. 649-663
Petersen, K.R., Skouby, S.O., Pedersen, R.G., Desogestrel and gestodene in oral contraceptives: 12 months' assessment of carbohydrate and lipoprotein metabolism (1991) Obstet Gynecol, 78, pp. 666-672
Spellacy, W.N., Tsibris, A.M., Tsibris, J.C., George, S., Chez, R.A., O'Brien, W.F., Carbohydrate metabolism studies after one year of using an oral contraceptive containing gestodene and ethinyl estradiol (1994) Contraception, 49, pp. 125-130
Miccoli, R., Orlandi, M.C., Fruzzetti, F., Metabolic effects of three new low-dose pills: A six-month experience (1989) Contraception, 39, pp. 643-652
Van Den Ende, A., Lütjens, A., Van Wayjen, R.G.A., Kloosterboer, H.J., Effects of the oral contraceptive combination 0.150 mg desogestrel plus 0.020 mg ethinylestradiol on carbohydrate metabolism in healthy female volunteers (1987) Acta Obstet Gynecol Scand, 144 (SUPPL.), pp. 29-32
Fioretti, P., Fruzzetti, F., Navalesi, R., Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel (1987) Contraception, 35, pp. 229-243
Godsland, I.F., Crook, D., Worthington, M., Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism (1993) Contraception, 48, pp. 217-227